Can-Fite Initiates Compassionate Use Program for Namodenoson in the Treatment of Liver Cancer, Enrolls and Treats Patients | Business Wire
Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry | npj Breast Cancer
Our Team – CTG-Pharma
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Transnational cancer research lab | Felsenstein Medical Research Center
Israel in Panama on Twitter: "Con el tema "Innovation and Entrepreneurship in the Health Care System" el Dr. Salomon Stemmer, Jefe de Investigación e Innovación en el Instituto de Oncología del Centro
Menendez co-defendant sentenced to 17 years in separate case | CNN Politics
Team - ADM Capital
Our Team – CTG-Pharma
The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
OncologyEducation a Twitter: "Dr. Salomon Stemmer provides an update of Namodenoson in patients with Child-Pugh B hepatocellular carcinoma in this video from #ASCO19: https://t.co/82i6FiWc4l https://t.co/SlkSpAAMot" / Twitter
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) - Annals of Oncology
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer | NEJM
Salomon Undhof — Vintage and Vine
COVID-19 vaccines effective for cancer patients, study finds - UPI.com
PLOS ONE: The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
First-of-its-kind study in Israel finds that cancer patients are safe for COVID-19 vaccines - EJP
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
COVID vaccine effective for 90% of cancer patients, Israeli study finds | The Times of Israel
Barak Pertzov (@barakpertzov) / Twitter
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Transnational cancer research lab | Felsenstein Medical Research Center
Faculty | CoBrCa – Controversies in Breast Cancer
